8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

1/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

2/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

3/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

4/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

5/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

6/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

7/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

8/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

9/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

10/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

11/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

12/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

13/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

14/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

15/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

16/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

17/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

18/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

19/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

20/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

21/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

22/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

23/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

24/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

25/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

26/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

27/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

28/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

29/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

30/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

31/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

32/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

33/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

34/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

35/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

36/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

37/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

38/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

39/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

40/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

41/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

42/43

8/10/2019 Patent-US 008343995 B2-Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use

43/43